NCT07751757

Brief Summary

Artificial intelligence (AI) technology is expected to assist clinical doctors in promptly identifying cancer patients at risk of developing psychological issues and to develop preemptive management plans, thereby enhancing their quality of life. Computer vision technology can directly capture and extract subtle changes in skin color from facial images in videos, assess heart rate using signal processing algorithms, and also extract facial expressions to evaluate psychological conditions through facial expression change signal processing algorithms. The accuracy rate can exceed 88%. By leveraging the capabilities of computer vision technology, it can accurately capture subtle movements and expressions of the human body, thereby understanding the internal psychological state and obtaining relevant psychological information

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
29mo left

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Mar 2021Dec 2028

Study Start

First participant enrolled

March 1, 2021

Completed
5.1 years until next milestone

First Submitted

Initial submission to the registry

March 25, 2026

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 7, 2026

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

August 7, 2026

Status Verified

August 1, 2026

Enrollment Period

7.8 years

First QC Date

March 25, 2026

Last Update Submit

August 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Area Under the Receiver Operating Characteristic Curve (AUC) of the Multimodal Machine Learning Model for Anxiety and Depression Screening

    The AUC quantifies the overall discriminative ability of the final multimodal machine learning model to distinguish between patients with positive vs. negative anxiety/depression status. The AUC will be calculated on an independent test set that is strictly separated from the training and validation sets and will not be used in any model training or hyperparameter tuning.

    Data collected at two time points: 1 day pre-operatively and at ≤7 days post-operatively or at discharge, whichever came first

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with cancers such as liver cancer, thyroid cancer and lung cancer et al. The demographic and clinical characteristics of tumor patients were collected and included, including age, gender, educational background, monthly income, marital status, ECOG score, liver function stage, Barcelona stage, recurrence frequency, lesion information, biochemical indicators, etc

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chinese PLA Hospital

Beijing, China

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Chief Physician

Study Record Dates

First Submitted

March 25, 2026

First Posted

August 7, 2026

Study Start

March 1, 2021

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

August 7, 2026

Record last verified: 2026-08

Locations